A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio

被引:109
作者
Fulghesu, AM [1 ]
Ciampelli, M [1 ]
Belosi, C [1 ]
Apa, R [1 ]
Pavone, V [1 ]
Lanzone, A [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Dept Obstet & Gynecol, I-00168 Rome, Italy
关键词
PCOS; ovarian stroma; ultrasound; hyperandrogenism;
D O I
10.1016/S0015-0282(01)01919-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate whether some ultrasound parameters of ovarian morphology can discriminate between control women and patients with polycystic ovary syndrome (PCOS). Design: Retrospective data analysis. Setting: Volunteers women in an academic research environment. Patient(s): Eighty amenorrheic or oligomenorrheic women and 30 normal ovulatory control participants. Intervention(s): None. Main Outcome Measure(s): We evaluated ovarian volume, area, stroma, and the stroma/total area (SIA) ratio by use of transvaginal pelvic ultrasound; and we assayed serum levels of gonadotropin, androgen, and estradiol during the early follicular phase (days 2 to 5) of the menstrual cycle in regularly cycling controls and on a random day in amenorrheic patients. Result(s): Patients with PCOS showed significantly higher ovarian volume, area, stroma, and mean S/A ratio when compared to multifollicular and control groups. Cut-off values have been defined for ovarian volume (13.21 mL), area (7.00 cm(2)), stroma. (1.95 cm(2)), and S/A ratio (0.34). The sensitivity for PCOS diagnosis was 21%, 4%, 62%, and 100%, respectively. The S/A ratio showed the most significant correlation with the androgen levels. Conclusion(s): The evaluation of the SIA ratio can differentiate between PCOS and control or multifollicular Za women with both a sensitivity and a specificity of 100%. Furthermore, this ultrasound parameter is strictly related to hormonal milieu and to anthropometric characteristics. (C) 2001 by American Society for Reproductive Medicine.
引用
收藏
页码:326 / 331
页数:6
相关论文
共 18 条
[1]  
ADAMS J, 1985, LANCET, V2, P1375
[2]  
ARDAENS Y, 1991, FERTIL STERIL, V55, P1062
[3]   Ovarian stromal echogenicity in women with normal and polycystic ovaries [J].
Buckett, WM ;
Bouzayen, R ;
Watkin, KL ;
Tulandi, T ;
Tan, SL .
HUMAN REPRODUCTION, 1999, 14 (03) :618-621
[4]   Insulin and polycystic ovary syndrome: a new look at an old subject [J].
Ciampelli, M ;
Lanzone, A .
GYNECOLOGICAL ENDOCRINOLOGY, 1998, 12 (04) :277-292
[5]   HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME - CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS [J].
CONWAY, GS ;
HONOUR, JW ;
JACOBS, HS .
CLINICAL ENDOCRINOLOGY, 1989, 30 (04) :459-470
[6]   OVARIAN STROMAL HYPERTROPHY IN HYPERANDROGENIC WOMEN [J].
DEWAILLY, D ;
ROBERT, Y ;
HELIN, I ;
ARDAENS, Y ;
THOMASDESROUSSEAUX, P ;
LEMAITRE, L ;
FOSSATI, P .
CLINICAL ENDOCRINOLOGY, 1994, 41 (05) :557-562
[7]  
Gosling R., 1975, ARTERIES VEINS, P61
[8]   Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone [J].
Lanzone, A ;
Guido, M ;
Ciampelli, M ;
Fulghesu, AM ;
Pavone, V ;
Proto, C ;
Caruso, A ;
Mancuso, S .
CLINICAL ENDOCRINOLOGY, 1996, 45 (01) :73-77
[9]   GENOTYPING STEROID 21-HYDROXYLASE DEFICIENCY - HORMONAL REFERENCE DATA [J].
NEW, MI ;
LORENZEN, F ;
LERNER, AJ ;
KOHN, B ;
OBERFIELD, SE ;
POLLACK, MS ;
DUPONT, B ;
STONER, E ;
LEVY, DJ ;
PANG, S ;
LEVINE, LS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (02) :320-326
[10]  
ORSINI LF, 1985, FERTIL STERIL, V43, P709